BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 1972772)

  • 1. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
    Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
    Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
    Moscow JA; Townsend AJ; Cowan KH
    Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transduction of NIH 3T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase pi produces broad-range multidrug resistance.
    Doroshow JH; Metz MZ; Matsumoto L; Winters KA; Sakai M; Muramatsu M; Kane SE
    Cancer Res; 1995 Sep; 55(18):4073-8. PubMed ID: 7664283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.
    Moscow JA; Fairchild CR; Madden MJ; Ransom DT; Wieand HS; O'Brien EE; Poplack DG; Cossman J; Myers CE; Cowan KH
    Cancer Res; 1989 Mar; 49(6):1422-8. PubMed ID: 2466554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
    Townsend AJ; Tu CP; Cowan KH
    Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
    Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
    Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene.
    Leyland-Jones BR; Townsend AJ; Tu CP; Cowan KH; Goldsmith ME
    Cancer Res; 1991 Jan; 51(2):587-94. PubMed ID: 1985777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.
    Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH
    Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S
    Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
    Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
    Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
    Schinkel AH; Roelofs EM; Borst P
    Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells.
    Fairchild CR; Ivy SP; Kao-Shan CS; Whang-Peng J; Rosen N; Israel MA; Melera PW; Cowan KH; Goldsmith ME
    Cancer Res; 1987 Oct; 47(19):5141-8. PubMed ID: 2441861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of the mouse multidrug resistance gene family.
    Dhir R; Buschman E; Gros P
    Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue.
    Terrier P; Townsend AJ; Coindre JM; Triche TJ; Cowan KH
    Am J Pathol; 1990 Oct; 137(4):845-53. PubMed ID: 1977319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.
    Hayes JD; Pulford DJ
    Crit Rev Biochem Mol Biol; 1995; 30(6):445-600. PubMed ID: 8770536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.